FORFARMERS NV (FFARM.AS) Stock Fundamental Analysis
AMS:FFARM - Euronext Amsterdam - NL0011832811 - Common Stock - Currency: EUR
FFARM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 56 industry peers in the Food Products industry. FFARM has only an average score on both its financial health and profitability. FFARM may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year FFARM was profitable.
FFARM had a positive operating cash flow in the past year.
FFARM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years FFARM had a positive operating cash flow.
1.2 Ratios
FFARM has a Return On Assets (3.33%) which is comparable to the rest of the industry.
FFARM has a Return On Equity (9.56%) which is in line with its industry peers.
FFARM has a better Return On Invested Capital (7.90%) than 71.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FFARM is below the industry average of 7.10%.
The 3 year average ROIC (4.52%) for FFARM is below the current ROIC(7.90%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.33% | ||
| ROE | 9.56% | ||
| ROIC | 7.9% |
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
1.3 Margins
Looking at the Profit Margin, with a value of 1.14%, FFARM is doing worse than 67.86% of the companies in the same industry.
In the last couple of years the Profit Margin of FFARM has grown nicely.
FFARM's Operating Margin of 2.02% is on the low side compared to the rest of the industry. FFARM is outperformed by 71.43% of its industry peers.
FFARM's Operating Margin has been stable in the last couple of years.
The Gross Margin of FFARM (18.88%) is worse than 78.57% of its industry peers.
In the last couple of years the Gross Margin of FFARM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.02% | ||
| PM (TTM) | 1.14% | ||
| GM | 18.88% |
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FFARM is still creating some value.
The number of shares outstanding for FFARM remains at a similar level compared to 1 year ago.
Compared to 5 years ago, FFARM has less shares outstanding
FFARM has a worse debt/assets ratio than last year.
2.2 Solvency
FFARM has an Altman-Z score of 3.79. This indicates that FFARM is financially healthy and has little risk of bankruptcy at the moment.
FFARM's Altman-Z score of 3.79 is amongst the best of the industry. FFARM outperforms 89.29% of its industry peers.
FFARM has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as FFARM would need 3.80 years to pay back of all of its debts.
FFARM's Debt to FCF ratio of 3.80 is fine compared to the rest of the industry. FFARM outperforms 76.79% of its industry peers.
FFARM has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, FFARM is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 3.79 |
ROIC/WACC1.19
WACC6.61%
2.3 Liquidity
FFARM has a Current Ratio of 1.11. This is a normal value and indicates that FFARM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.11, FFARM is doing worse than 67.86% of the companies in the same industry.
FFARM has a Quick Ratio of 1.11. This is a bad value and indicates that FFARM is not financially healthy enough and could expect problems in meeting its short term obligations.
FFARM has a Quick ratio of 0.82. This is comparable to the rest of the industry: FFARM outperforms 48.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
FFARM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4895.65%, which is quite impressive.
Measured over the past years, FFARM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.71% on average per year.
The Revenue has decreased by -7.70% in the past year.
The Revenue has been growing slightly by 2.20% on average over the past years.
EPS 1Y (TTM)4895.65%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%83.47%
Revenue 1Y (TTM)-7.7%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%1.62%
3.2 Future
The Earnings Per Share is expected to grow by 32.03% on average over the next years. This is a very strong growth
FFARM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.29% yearly.
EPS Next Y70.55%
EPS Next 2Y33.7%
EPS Next 3Y32.03%
EPS Next 5YN/A
Revenue Next Year6.99%
Revenue Next 2Y4.44%
Revenue Next 3Y5.29%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.12, FFARM is valued correctly.
67.86% of the companies in the same industry are more expensive than FFARM, based on the Price/Earnings ratio.
FFARM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.79.
With a Price/Forward Earnings ratio of 9.36, the valuation of FFARM can be described as very reasonable.
Based on the Price/Forward Earnings ratio, FFARM is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, FFARM is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.12 | ||
| Fwd PE | 9.36 |
4.2 Price Multiples
FFARM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FFARM is cheaper than 83.93% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, FFARM is valued a bit cheaper than 78.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.5 | ||
| EV/EBITDA | 4.12 |
4.3 Compensation for Growth
FFARM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FFARM's earnings are expected to grow with 32.03% in the coming years.
PEG (NY)0.17
PEG (5Y)0.82
EPS Next 2Y33.7%
EPS Next 3Y32.03%
5. Dividend
5.1 Amount
FFARM has a Yearly Dividend Yield of 5.09%, which is a nice return.
FFARM's Dividend Yield is rather good when compared to the industry average which is at 3.21. FFARM pays more dividend than 89.29% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.47, FFARM pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.09% |
5.2 History
The dividend of FFARM decreases each year by -12.97%.
Dividend Growth(5Y)-12.97%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
41.40% of the earnings are spent on dividend by FFARM. This is a bit on the high side, but may be sustainable.
DP41.4%
EPS Next 2Y33.7%
EPS Next 3Y32.03%
AMS:FFARM (4/25/2025, 7:00:00 PM)
4
+0.07 (+1.78%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners5.54%
Inst Owner ChangeN/A
Ins Owners5.49%
Ins Owner ChangeN/A
Market Cap357.12M
Analysts44.44
Price Target4.28 (7%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.09% |
Yearly Dividend0.15
Dividend Growth(5Y)-12.97%
DP41.4%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.44%
PT rev (3m)21.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)41.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.77%
Revenue NY rev (3m)5.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.12 | ||
| Fwd PE | 9.36 | ||
| P/S | 0.13 | ||
| P/FCF | 8.5 | ||
| P/OCF | 5.09 | ||
| P/B | 1.09 | ||
| P/tB | 1.71 | ||
| EV/EBITDA | 4.12 |
EPS(TTM)0.33
EY8.25%
EPS(NY)0.43
Fwd EY10.69%
FCF(TTM)0.47
FCFY11.76%
OCF(TTM)0.79
OCFY19.66%
SpS30.75
BVpS3.68
TBVpS2.34
PEG (NY)0.17
PEG (5Y)0.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.33% | ||
| ROE | 9.56% | ||
| ROCE | 10.29% | ||
| ROIC | 7.9% | ||
| ROICexc | 8.67% | ||
| ROICexgc | 11.28% | ||
| OM | 2.02% | ||
| PM (TTM) | 1.14% | ||
| GM | 18.88% | ||
| FCFM | 1.53% |
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
ROICexc(3y)5.02%
ROICexc(5y)6.01%
ROICexgc(3y)6.45%
ROICexgc(5y)7.81%
ROCE(3y)5.89%
ROCE(5y)6.6%
ROICexcg growth 3Y23.14%
ROICexcg growth 5Y0.01%
ROICexc growth 3Y22.42%
ROICexc growth 5Y1.04%
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
F-Score6
Asset Turnover2.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 1.39 | ||
| Cap/Depr | 55.29% | ||
| Cap/Sales | 1.03% | ||
| Interest Coverage | 8.27 | ||
| Cash Conversion | 65.98% | ||
| Profit Quality | 133.76% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 3.79 |
F-Score6
WACC6.61%
ROIC/WACC1.19
Cap/Depr(3y)70.12%
Cap/Depr(5y)76.46%
Cap/Sales(3y)1.08%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4895.65%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%83.47%
EPS Next Y70.55%
EPS Next 2Y33.7%
EPS Next 3Y32.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.7%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%1.62%
Revenue Next Year6.99%
Revenue Next 2Y4.44%
Revenue Next 3Y5.29%
Revenue Next 5YN/A
EBIT growth 1Y201.09%
EBIT growth 3Y24.06%
EBIT growth 5Y0.93%
EBIT Next Year182.01%
EBIT Next 3Y50.85%
EBIT Next 5YN/A
FCF growth 1Y-19.39%
FCF growth 3Y40.78%
FCF growth 5Y-6.65%
OCF growth 1Y-18.84%
OCF growth 3Y8.69%
OCF growth 5Y-6.1%